Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Lymphoproliferative Disorders × Positron-Emission Tomography × Clear all

Sponsor

Conditions

Prostatic Neoplasms 6 Lymphoma, Non-Hodgkin 3 Neoplasms 2 Neoplasm Metastasis 2 Lymphoma 2 Disease 2 Carcinoma, Hepatocellular 2 Breast Neoplasms 2 Vulvar Neoplasms 1 Vulvar Diseases 1 Vasculitis 1 Uterine Cervical Neoplasms 1 Uterine Cervical Dysplasia 1 Urinary Bladder Neoplasms 1 Triple Negative Breast Neoplasms 1 Squamous Cell Carcinoma of Head and Neck 1 Smoking Cessation 1 Papillomavirus Infections 1 Osteomyelitis 1 Nose Neoplasms 1 Myelodysplastic Syndromes 1 Multiple Pulmonary Nodules 1 Multiple Myeloma 1 Melanoma 1 Lymphoma, Large-Cell, Anaplastic 1 Lymphoma, Large B-Cell, Diffuse 1 Lymphoma, Follicular 1 Lung Neoplasms 1 Liver Neoplasms 1 Leukemia 1

Interventions

blinatumomab 6 Tacrolimus 3 Rituximab 3 Cyclophosphamide 3 ponatinib 2 fludarabine 2 Vorinostat 2 Vincristine 2 Prednisone 2 Peripheral Blood Stem Cell Transplantation 2 Methotrexate 2 Everolimus 2 Etoposide 2 Doxorubicin 2 Darbepoetin alfa 2 Busulfan 2 Brentuximab Vedotin 2 Antilymphocyte Serum 2 tetulomab tetraxetan lu-177 1 ruxolitinib 1 pegaspargase 1 ibritumomab tiuxetan 1 fludarabine phosphate 1 ferrous sulfate 1 ferric gluconate 1 denileukin diftitox 1 cobomarsen 1 asparaginase erwinia chrysanthemi recombinant 1 Tomography, X-Ray Computed 1 Therapeutics 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡